Global Measurements of Protein Folding Stability for Characterization of Aging and Disease

用于表征衰老和疾病的蛋白质折叠稳定性的全局测量

• 批准号: 10473697
• 负责人: Michael C Fitzgerald
• 金额: $ 30.27万
• 依托单位: DUKE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-09-23 至 2023-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10473697
• 关键词: Aging; Biological; Biological Assay; Biological Process; Biology; Brain; Cell Line; Chemicals; Clinical; Colorectal; Colorectal Cancer; Development; Disease; Drug resistance; Gene Expression; Gene Expression Profiling; Genome; Left; Lip structure; Malignant Neoplasms; Mass Spectrum Analysis; Measurement; Metastatic Neoplasm to the Liver; Methodology; Methods; Modification; Molecular; Molecular Conformation; Mouse Protein; Mus; Organoids; Pathway interactions; Patients; Physiological Processes; Pilot Projects; Property; Proteins; Proteolysis; Proteome; Proteomics; Research; Resistance; Sampling; Specimen; Techniques; Thermodynamics; Tissue-Specific Gene Expression; Work; aged; base; brain tissue; clinically relevant; colon cancer cell line; design; drug sensitivity; drug-sensitive; human disease; mouse model; novel; oxaliplatin; patient derived xenograft model; predictive test; protein biomarkers; protein expression; protein folding; protein function; therapeutic target; tumor

ABSTRACT Genome- and proteome-based gene expression profiling studies have been widely used over the past decade to characterize biological states including those associated with normal biological process (e.g., aging) and with disease (e.g., cancer). While such differential gene expression profiling studies can help identify the cellular pathways and physiological processes associated with a biological state they often fail to produce a complete understanding of the biological state because gene expression levels are not directly tied to protein function. This has limited the number of useful protein biomarkers and therapeutic targets discovered from such studies, and left gaps in our understanding of disease states. Proposed here is the development and application of thermodynamic measurements of protein stability to characterize different biological states including those associated with aging and cancer. Such thermodynamic measurements of protein stability are expected to be more closely related to protein function than are protein expression levels, and thus produce more useful protein biomarkers and therapeutic targets of disease and generate a better understanding of the molecular basis of disease. The proposed work will further develop and utilize three mass spectrometry-based proteomics methods, termed SPROX, LiP and PP, to characterize the protein folding and stability changes associated with a fundamental biological process, aging, and a disease, colorectal cancer. The specific aims of this work are: (1) to interface SPROX and LiP with middle- down proteomics methods to enable proteoform specific folding and stability measurments; (2) to utilize the middle down SPROX and LiP workflows developed in (1) to make proteoform specific thermodynamic stability measurements on mouse brain proteins derived from a mouse model of aging; (3) to utilize the SPROX, LiP, and PP techniques to identify protein biomarker with altered folding and stability in patient-derived colorectal cancer cell lines with different sensitivities to oxaliplatin treatment; (4) to utilize the protein biomarkers discovered in (3) to develop a clinically relevant assay for predicting oxaliplatin resistance/sensitivity in colorectal cancer.

摘要 基于基因组和蛋白质组的基因表达谱研究已被广泛应用 在过去的十年中，生物状态的特点，包括那些与正常 生物过程（例如，老化）和疾病（例如，癌症）。虽然这种差异基因 表达谱研究可以帮助识别细胞通路和生理过程 与生物状态相关，他们往往无法完全理解 因为基因表达水平与蛋白质功能没有直接关系。这 限制了从这些蛋白质中发现的有用的蛋白质生物标志物和治疗靶标的数量， 研究，并在我们对疾病状态的理解中留下了空白。这里提出的是发展 以及应用蛋白质稳定性的热力学测量来表征不同的 生物状态，包括与衰老和癌症相关的生物状态。这种热力学 预计蛋白质稳定性的测量与蛋白质功能更密切相关 比蛋白质表达水平更高，从而产生更有用的蛋白质生物标志物， 疾病的治疗靶点，并产生更好的理解的分子基础， 疾病 拟议的工作将进一步发展和利用三个质谱为基础的 蛋白质组学方法，称为SPROX，LiP和PP，以表征蛋白质折叠和 与基本生物过程、衰老和疾病相关的稳定性变化， 结肠直肠癌本工作的具体目标是：（1）将SPROX和LiP与中- 下调蛋白质组学方法，以实现蛋白质型特异性折叠和稳定性测量;（2） 利用在（1）中开发的中间向下SPROX和LiP工作流程来制备蛋白质型， 对源自小鼠的小鼠脑蛋白的特定热力学稳定性测量 （3）利用SPROX、LiP和PP技术鉴定蛋白质生物标志物 在具有不同基因的患者来源的结直肠癌细胞系中， 对奥沙利铂治疗的敏感性;（4）利用（3）中发现的蛋白质生物标志物， 开发预测结直肠癌患者奥沙利铂耐药/敏感性的临床相关试验 癌